Screening of monogenic autoimmune diabetes among children with type 1 diabetes and multiple autoimmune diseases: is it worth doing?
Adolescent
Autoantibodies
/ immunology
Autoimmune Diseases
/ diagnosis
Child
Child, Preschool
Cohort Studies
Diabetes Mellitus, Type 1
/ diagnosis
Female
Follow-Up Studies
Genetic Markers
Genetic Predisposition to Disease
Genetic Testing
Humans
Infant
Infant, Newborn
Male
Mutation
Phenotype
Prognosis
CTLA4
IPEX syndrome
STAT3
T1D-GRS
monogenic autoimmune diabetes
Journal
Journal of pediatric endocrinology & metabolism : JPEM
ISSN: 2191-0251
Titre abrégé: J Pediatr Endocrinol Metab
Pays: Germany
ID NLM: 9508900
Informations de publication
Date de publication:
25 Oct 2019
25 Oct 2019
Historique:
received:
09
06
2019
accepted:
09
08
2019
pubmed:
5
9
2019
medline:
4
3
2020
entrez:
5
9
2019
Statut:
ppublish
Résumé
Background Paediatric type 1 diabetes (T1D) and rare syndromes of monogenic multi-organ autoimmunity share basic features such as full insulin dependency and the presence of circulating beta-cell autoantibodies. However, the aetiopathogenesis, natural course and treatment of these conditions differ; therefore, monogenic multi-organ autoimmunity requires early recognition. We aimed to search for these monogenic conditions among a large cohort of children with T1D. Methods Of 519 children with T1D followed-up in a single centre, 18 had multiple additional autoimmune conditions - either autoimmune thyroid disease (AITD) and coeliac disease (CD) or at least one additional organ-specific autoimmune condition in addition to AITD or CD. These 18 children were tested by direct Sanger sequencing (four patients with a suggestive phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-linked [IPEX] or signal transducer and activator of transcription 3 [STAT3]- and cytotoxic T-lymphocyte protein 4 [CTLA4]-associated syndromes) or by whole-exome sequencing (WES) focused on autoimmune regulator (AIRE), forkhead box protein 3 (FOXP3), CTLA4, STAT3, signal transducer and activator of transcription 1 (STAT1), lipopolysaccharide-responsive and beige-like anchor protein (LRBA) and interleukin-2 receptor subunit α (IL2RA) genes. In addition, we assessed their T1D genetic risk score (T1D-GRS). Results We identified novel variants in FOXP3, STAT3 and CTLA4 in four cases. All patients had a severe phenotype suggestive of a single gene defect. No variants were identified in the remaining 14 patients. T1D-GRS varied among the entire cohort; four patients had scores below the 25th centile including two genetically confirmed cases. Conclusions A monogenic cause of autoimmune diabetes was confirmed only in four patients. Genetic screening for monogenic autoimmunity in children with a milder phenotype and a combination of AITD and CD is unlikely to identify a monogenic cause. In addition, the T1D-GRS varied among individual T1D patients.
Identifiants
pubmed: 31483759
doi: 10.1515/jpem-2019-0261
pii: /j/jpem.ahead-of-print/jpem-2019-0261/jpem-2019-0261.xml
doi:
pii:
Substances chimiques
Autoantibodies
0
Genetic Markers
0
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM